Streetbeat News

Stock Prices

PVH

PVH shares are experiencing a decline as the company forecasts a decrease in Q3 revenue and provides EPS estimates that fall below expectations.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 11:13 am

PDCO

Patterson Companies has reaffirmed its 2025 adjusted EPS guidance of $2.33-$2.43, which aligns closely with the consensus estimate of $2.36.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 11:13 am

AMBA

Ambarella shares rose following the company's announcement of better-than-expected Q2 adjusted EPS and sales.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 11:12 am

KRYS

Jeune Aesthetics, a subsidiary of Krystal Biotech, announced positive interim results from the PEARL-1 Phase 1 study evaluating KB301 for treating lateral canthal lines and dynamic wrinkles of the décolleté. This development could positively impact Krystal Biotech's stock.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 11:11 am

NVDA

SOX

Nvidia is set to announce its Q2 results, with analysts expecting strong growth driven by AI demand. Concerns over a potential delay in the Blackwell AI accelerator are present, but analysts remain optimistic about Nvidia's leadership in AI and accelerated computing.

Portfolio Pulse from Shanthi Rexaline

August 28, 2024 | 11:09 am

NBIX

Neurocrine Biosciences announced positive top-line results from its Phase 2 clinical study of NBI-1117568, a treatment for adults with schizophrenia. This development could impact the company's stock positively.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 11:09 am

CHWY

Chewy shares are trading higher following the release of their Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 11:07 am

AVIR

Atea Pharmaceuticals published new data on the metabolic activation pathway of bemnifosbuvir, an antiviral in development for COVID-19 and HCV treatment.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 11:07 am

CHWY

Chewy reported its Q2 2024 adjusted EPS at $0.24, which may not be comparable to the $0.02 estimate. However, its sales of $2.859 billion missed the $2.869 billion estimate.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 11:06 am

KSS

Kohl's reported a gross margin of 39.6% for Q2, which is an increase of 59 basis points. This improvement in margin could indicate better cost management or pricing strategies.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 11:05 am